WallStreetZenWallStreetZen

NASDAQ: NOTV
Inotiv Inc Stock Forecast, Predictions & Price Target

Analyst price target for NOTV

Based on 3 analysts offering 12 month price targets for Inotiv Inc.
Min Forecast
$2.00-1.96%
Avg Forecast
$5.25+157.35%
Max Forecast
$10.00+390.2%

Should I buy or sell NOTV stock?

Based on 3 analysts offering ratings for Inotiv Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NOTV stock forecasts and price targets.

NOTV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-05-14

1 of 1

Forecast return on equity

Is NOTV forecast to generate an efficient return?

Forecast return on assets

Is NOTV forecast to generate an efficient return on assets?

NOTV revenue forecast

What is NOTV's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$510.6M-7.63%
Avg 2 year Forecast
$544.1M-1.57%
Avg 3 year Forecast
$579.9M+4.91%
NOTV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NOTV revenue growth forecast

How is NOTV forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-0.72%
Industry
5.91%
Market
9.3%
NOTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NOTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NOTV vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NOTV$2.04$5.25+157.35%Hold
DRIO$1.74$4.00+129.89%Strong Buy
ENZ$1.06N/AN/A
TTOO$5.63$3.00-46.71%Hold
VNRX$0.72$3.50+383.43%Strong Buy

Inotiv Stock Forecast FAQ

Is Inotiv Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: NOTV) stock is to Hold NOTV stock.

Out of 3 analysts, 0 (0%) are recommending NOTV as a Strong Buy, 1 (33.33%) are recommending NOTV as a Buy, 2 (66.67%) are recommending NOTV as a Hold, 0 (0%) are recommending NOTV as a Sell, and 0 (0%) are recommending NOTV as a Strong Sell.

If you're new to stock investing, here's how to buy Inotiv stock.

What is NOTV's revenue growth forecast for 2024-2026?

(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of -0.72% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Inotiv's revenue in 2024 is $552,744,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2024 to be $13,259,983,512, with the lowest NOTV revenue forecast at $13,259,983,512, and the highest NOTV revenue forecast at $13,259,983,512. On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $14,130,286,802, with the lowest NOTV revenue forecast at $14,130,286,802, and the highest NOTV revenue forecast at $14,130,286,802.

In 2026, NOTV is forecast to generate $15,060,324,426 in revenue, with the lowest revenue forecast at $15,060,324,426 and the highest revenue forecast at $15,060,324,426.

What is NOTV's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: NOTV) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 0.02%.

What is NOTV's Price Target?

According to 3 Wall Street analysts that have issued a 1 year NOTV price target, the average NOTV price target is $5.25, with the highest NOTV stock price forecast at $10.00 and the lowest NOTV stock price forecast at $2.00.

On average, Wall Street analysts predict that Inotiv's share price could reach $5.25 by May 16, 2025. The average Inotiv stock price prediction forecasts a potential upside of 157.35% from the current NOTV share price of $2.04.

What is NOTV's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: NOTV) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.